CompletedNot Applicable

Surgicel® Fibrillar for Delayed Bleeding After ESD

South Korea146 participantsStarted 2012-12

Plain-language summary

The aim of this study is to assess the effect of Surgicel® Fibrillar as adjuvant treatment to H2RA on preventing ulcer bleeding after ESD for gastric epithelial tumors

Who can participate

Age range20 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * ESD for gastric dysplasia or early gastric cancer Exclusion Criteria: * Coagulopathy: liver cirrhosis, thrombocytopenia * Anti-platelet agents

What they're measuring

Delayed bleeding rate after ESD

Timeframe: 1 year

Trial details

NCT IDNCT01758965

SponsorSoonchunhyang University Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2013-12

View on ClinicalTrials.gov More Benign Neoplasm of Stomach trials